| Finding the dose for hydroxychloroquine prophylaxis for COVID‐19: the desperate search for effectiveness M Al‐Kofahi, P Jacobson, DR Boulware, A Matas, R Kandaswamy, ... Clinical Pharmacology & Therapeutics 108 (4), 766-769, 2020 | 66 | 2020 |
| Lymphatic dysregulation in intestinal inflammation: new insights into inflammatory bowel disease pathomechanisms F Becker, P Yi, M Al-Kofahi, VC Ganta, J Morris, JS Alexander Lymphology 47 (1), 3-27, 2014 | 36 | 2014 |
| IL‐1β reduces tonic contraction of mesenteric lymphatic muscle cells, with the involvement of cycloxygenase‐2 and prostaglandin E2 M Al‐Kofahi, F Becker, FNE Gavins, MD Woolard, I Tsunoda, Y Wang, ... British journal of pharmacology 172 (16), 4038-4051, 2015 | 30 | 2015 |
| Anatomy and roles of lymphatics in inflammatory diseases M Al‐Kofahi, JW Yun, A Minagar, JS Alexander Clinical and Experimental Neuroimmunology 8 (3), 199-214, 2017 | 29 | 2017 |
| IL-1β reduces cardiac lymphatic muscle contraction via COX-2 and PGE2 induction: Potential role in myocarditis M Al-Kofahi, S Omura, I Tsunoda, F Sato, F Becker, FNE Gavins, ... Biomedicine & Pharmacotherapy 107, 1591-1600, 2018 | 23 | 2018 |
| An integrated PK‐PD model for cortisol and the 17‐hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia M Al‐Kofahi, MA Ahmed, MM Jaber, TN Tran, BA Willis, CL Zimmerman, ... British Journal of Clinical Pharmacology, 2020 | 20 | 2020 |
| Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome M Okour, M Al-Kofahi, D Austin Journal of pharmacokinetics and pharmacodynamics 47, 187-188, 2020 | 20 | 2020 |
| Theiler's virus-mediated immunopathology in the CNS and heart: roles of organ-specific cytokine and lymphatic responses S Omura, E Kawai, F Sato, NE Martinez, A Minagar, M Al-Kofahi, JW Yun, ... Frontiers in immunology 9, 2870, 2018 | 17 | 2018 |
| Reduced enterohepatic recirculation of mycophenolate and lower blood concentrations are associated with the stool bacterial microbiome after hematopoietic cell transplantation A Saqr, B Carlson, C Staley, A Rashidi, M Al-Kofahi, T Kaiser, S Holtan, ... Transplantation and Cellular Therapy 28 (7), 372. e1-372. e9, 2022 | 13 | 2022 |
| 1,25(OH)2D3 Induces Placental Vascular Smooth Muscle Cell Relaxation by Phosphorylation of Myosin Phosphatase Target Subunit 1Ser507: Potential … X Jia, Y Gu, LJ Groome, M Al-Kofahi, JS Alexander, W Li, Y Wang Biology of reproduction 94 (5), 116, 1-8, 2016 | 13 | 2016 |
| Pharmacokinetic—pharmacodynamic modeling of tumor targeted drug delivery using nano-engineered mesenchymal stem cells S Cheng, SK Nethi, M Al-Kofahi, S Prabha Pharmaceutics 13 (1), 92, 2021 | 11 | 2021 |
| Bupivacaine pharmacokinetics and breast milk excretion of liposomal bupivacaine administered after cesarean birth HJ Mustafa, HL Wong, M Al-Kofahi, M Schaefer, A Karanam, MM Todd Obstetrics & Gynecology 136 (1), 70-76, 2020 | 11 | 2020 |
| Precision dosing for tacrolimus using genotypes and clinical factors in kidney transplant recipients of european ancestry M Al‐Kofahi, WS Oetting, DP Schladt, RP Remmel, W Guan, B Wu, ... The Journal of Clinical Pharmacology 61 (8), 1035-1044, 2021 | 5 | 2021 |
| Individualized absorption models in population pharmacokinetic analyses MM Jaber, M Al‐Kofahi, K Sarafoglou, RC Brundage CPT: Pharmacometrics & Systems Pharmacology 9 (6), 307, 2020 | 5 | 2020 |
| Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events T Takahashi, M Al-Kofahi, M Jaber, B Bratrude, K Betz, Y Suessmuth, ... Blood 142 (8), 700-710, 2023 | 4 | 2023 |
| Physiologically‐Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug–Drug Interactions SA Sahasrabudhe, S Cheng, M Al‐Kofahi, JR Jarnes, NJ Weinreb, ... Clinical Pharmacology & Therapeutics 112 (6), 1254-1263, 2022 | 2 | 2022 |
| A model-based pharmacokinetic/pharmacodynamic analysis of hydrocortisone, 17-hydroxyprogesterone (17OHP), and androstenedione (D4A) in children with congenital adrenal … MA Ahmed, K Sarafoglou, M Al-Kofahi, MT Gonzalez-Bolanos, ... JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 43, S89-S89, 2016 | 2 | 2016 |
| Population Pharmacokinetic Model of Intravenous Busulfan in Hematopoietic Cell Transplantation: Systematic Review and Comparative Simulations T Takahashi, MM Jaber, SJ Brown, M Al-Kofahi Clinical Pharmacokinetics 62 (7), 955-968, 2023 | 1 | 2023 |
| Influence of Renal Function on Phosphoramide Mustard Exposure: A Nonlinear Mixed‐Effects Analysis MM Jaber, T Takahashi, MN Kirstein, M Al‐Kofahi, PA Jacobson, ... The Journal of Clinical Pharmacology 63 (1), 135-142, 2023 | 1 | 2023 |
| Comparison of Dose Adjustment Strategies for Obesity in High-dose Cyclophosphamide Among Adult Hematopoietic Cell Transplantation Recipients: Pharmacokinetic Analysis T Takahashi, MM Jaber, M Al-Kofahi, D Weisdorf, C Brunstein, ... Transplantation and Cellular Therapy 28 (12), 845. e1-845. e8, 2022 | 1 | 2022 |
